Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Glycosylated integral membrane protein 1 (GINM1)** is a human protein encoded by the GINM1 gene, previously known as C6orf72[14][3][12]. It is classified as an integral membrane glycoprotein based on sequence data and predicted structure but lacks experimental evidence for a specific molecular function, biological process, or disease association[14][10]. GINM1 is expressed in multiple tissues according to RNA and protein expression data, but no clinical, pharmacological, or pathogenic roles have been established, and it is not currently considered a therapeutic target or biomarker[10][14][9][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosylated integral membrane protein 1 (GINM1).